Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation

Hopewell S. et al, (2025), Ewha Medical Journal

Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

Roope LSJ. et al, (2025), Contemporary Clinical Trials Communications, 45

Clustering of Multimorbidity and Social Care Needs: 10-year all-cause mortality in a cohort study of more than 7 million people

Islam N. et al, (2025)

SPIRIT 2025 statement: updated guideline for protocols of randomized trials.

Chan A-W. et al, (2025), Nat Med

SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.

Hróbjartsson A. et al, (2025), BMJ, 389

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Chan A-W. et al, (2025), BMJ, 389

CONSORT 2025 statement: updated guideline for reporting randomized trials.

Hopewell S. et al, (2025), Nat Med

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), BMJ, 389

CONSORT 2025 statement: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), BMJ, 389

CONSORT 2025 statement: Updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), PLoS Med, 22

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.

Chan A-W. et al, (2025), PLoS Med, 22

The association of loneliness and social isolation with multimorbidity over 14 years in older adults in England: A population-based cohort study

Hounkpatin H. et al, (2025), Archives of Gerontology and Geriatrics, 131

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study

Dennis JM. et al, (2025), The Lancet, 405, 701 - 714

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes

Sammons E. et al, (2025), BMJ Open, 15

Implementation of evidence-based foot screening in people with diabetes: A scoping review.

Houghton JM. et al, (2025), J Diabetes Complications, 39

Challenges and barriers to physician decision-making for prescribing and deprescribing among patients with multimorbidity in eastern China's primary care settings: A qualitative study

Zhou X. et al, (2025), BMJ Open, 15

The Digital Health Competencies in Medical Education Framework: An International Consensus Statement Based on a Delphi Study

Car J. et al, (2025), JAMA network open, 8

CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials

Hopewell S. et al, (2025), JAMA

Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study

Cardoso P. et al, (2025), Diabetes Obesity and Metabolism

SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized Trials

Chan AW. et al, (2025), JAMA

Load More

1
2
3
4
5
6
7
...
»